PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1495572
PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1495572
Bioprocess Analyzers Market - By Product, Analysis Type, Application, End-use - Global Forecast
Bioprocess analyzers market size will record 15.2% CAGR between 2024 and 2032. The increasing adoption of biopharmaceuticals for the treatment of various diseases, including cancer, autoimmune disorders, and infectious diseases is fueling the demand for bioprocess analyzers to monitor and optimize biopharmaceutical production processes. As per WHO, in 2022, approximately 20 million new cancer diagnoses were recorded, with fatalities reaching 9.7 million. As the biopharmaceutical industry continues to expand globally, driven by advancements in biotechnology and personalized medicine, there is a growing need for advanced analytical tools to ensure product quality, consistency, and regulatory compliance.
Rising technological advancements in bioprocess analyzers, including the integration of automation, miniaturization, and advanced sensor technologies, enhance their efficiency, accuracy, and reliability, driving their adoption across biopharmaceutical manufacturing facilities. These advanced analyzers enable real-time monitoring of critical process parameters, such as cell viability, metabolite concentrations, and product titers, facilitating process optimization and faster time-to-market for biopharmaceutical products.
The bioprocess analyzer industry is classified into product, analysis type, application, end use and region
Based on product, the market value from the instruments segment is expected to witness 15.4% CAGR through 2032. Rapid advancements in bioprocess technology and increasing demand for biopharmaceuticals are necessitating sophisticated analytical instruments capable of monitoring and optimizing complex bioprocessing workflows. Instruments, such as spectrophotometers, chromatography systems, and mass spectrometers, enable real-time analysis of critical process parameters for ensuring product quality, consistency, and regulatory compliance.
bioprocess analyzers market from the antibiotics application segment is slated to generate notable revenue at 15.4% CAGR during 2024-2032. The increasing prevalence of infectious diseases and antibiotic-resistant pathogens is driving the demand for novel antibiotics and antimicrobial agents, necessitating efficient bioprocesses for their production. To that end, bioprocess analyzers help in optimizing fermentation and purification processes while ensuring the quality, yield, and consistency of antibiotic production.
Asia Pacific bioprocess analyzers market size will record a 15.8% growth rate through 2032. The expanding biopharmaceutical sector, fueled by increasing demand for personalized medicine and biologics, is necessitating advanced analytical tools for process optimization and quality control in bioprocessing workflows. Rapid technological advancements in bioprocess analyzers, such as automation, miniaturization, and real-time monitoring capabilities to enhance their efficiency and accuracy will further drive the regional market growth.
Table of Contents
Chapter 1 Methodology & Scope
- 1.1 Market scope & definitions
- 1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
- 1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
- 1.4 Forecast model
- 1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources
Chapter 2 Executive Summary
- 2.1 Industry 360 degree synopsis
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Growing demand for biopharmaceutical products
- 3.2.1.2 Advancements in biotechnology and bioprocessing
- 3.2.1.3 Increasing demand for biosimilars
- 3.2.1.4 Rising government initiatives and funding
- 3.2.2 Industry pitfalls & challenges
- 3.2.2.1 High cost of instruments
- 3.2.2.2 Complexity and technical expertise
- 3.2.1 Growth drivers
- 3.3 Growth potential analysis
- 3.4 Regulatory landscape
- 3.5 Technological landscape
- 3.6 Porter's analysis
- 3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
- 4.1 Introduction
- 4.2 Company market share analysis
- 4.3 Competitive positioning matrix
- 4.4 Strategy outlook matrix
Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)
- 5.1 Key trends
- 5.2 Instruments
- 5.3 Consumables & accessories
Chapter 6 Market Estimates and Forecast, By Analysis Type, 2021 - 2032 ($ Mn)
- 6.1 Key trends
- 6.2 Substrate analysis
- 6.3 Metabolite analysis
- 6.4 Contentration detection
Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)
- 7.1 Key trends
- 7.2 Antibiotics
- 7.3 Recombinant proteins
- 7.4 Biosimilars
- 7.5 Other applications
Chapter 8 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)
- 8.1 Key trends
- 8.2 Biopharmaceutical companies
- 8.3 CROs & CMOs
- 8.4 Research & academic institutes
- 8.5 Other end-users
Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)
- 9.1 Key trends
- 9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
- 9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Rest of Europe
- 9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
- 9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Rest of Latin America
- 9.6 Middle East and Africa
- 9.6.1 Saudi Arabia
- 9.6.2 South Africa
- 9.6.3 UAE
- 9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
- 10.1 Agilent Technologies, Inc.
- 10.2 Algenax
- 10.3 Danaher Corporation
- 10.4 F. Hoffmann-La Roche Ltd.
- 10.5 Groton Biosystems LLC
- 10.6 Kaiser Optical Systems, Inc.
- 10.7 Nova Biomedical
- 10.8 Randox Laboratories Ltd.
- 10.9 Sartorius AG
- 10.10 SYSBIOTECH GmbH
- 10.11 Thermo Fisher Scientific Inc.
- 10.12 YSI Inc.
